PATENT CLAIM ANALYSIS

Application Number: 15937271
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "210180"]

Abstract:
The present invention relates to inhibitors of bromo and extra terminal (BET) bromodomains that are useful for the treatment of cancer, inflammatory diseases, diabetes, and obesity, having Formula I: wherein W, X, Y, Z, R 1 , R 2 , R 5 , and R 8  are as described herein.

Claim (Index 4):
The compound of  claim 1 , having the Formula II or a pharmaceutically acceptable salt, enantiomer, hydrate, solvate, prodrug, isomer, or tautomer thereof, wherein: W is O, C(O), or CHR 3 ; Ar is aryl or heteroaryl; R 2  is hydrogen or NR a R b ; R 3  is hydrogen, hydroxy, or halo; R 4  hydrogen, \u2014O(CH 2 ) n R d , \u2014O(CH 2 ) n C(O)R d , or \u2014O(CH 2 ) n S(O) 2 R d ; R 7  is hydrogen or halo; R 8  is R a , \u2014OR a , or heterocycloalkyl; R a  and R b  are independently hydrogen, C 1 -C 6  alkyl, heterocycloalkyl, or cycloalkyl; R c  is R a , \u2014(CH 2 ) n OR a , \u2014C(O)R a , \u2014C(O)OR a , \u2014C(O)NR a R b  \u2014S(O) 2 R a , halo, or oxo; and n is 0, 1, or 2.

Metadata:
- Claim Count in Document: 68.0
- Percentile: 90.0
- Lexical Diversity: 1.37778
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14546775', '14546896', '12641063', '13347364', '15757199']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8081380620642133
- 35 USC 102 Novelty (BERT): 0.6644437777882243
- Combined Prediction Score: 0.7937686336366144
- Mean Citation Score: 423.176318
- Max Citation Score: 655.55743
- Similarity Product: 650.7016707473267

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test